Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abiomed receives PMA (premarket approval) supplement:

This article was originally published in Clinica

Executive Summary

The FDA has given Abiomed a premarket approval supplement for four of its new atrial cannulae featured in the BVS artificial heart system. The cardiac assist device gives temporary circulatory support to failed transplant patients, those who fail to come off cardiopulmonary bypass after heart surgery and those who require right heart support after insertion of an implantable left ventricular assist device.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts